The 2021 Medtech Contract Manufacturing Report


Interviews with Medtech Innovation Leaders

Scott Huennekens, Chairman of the Board, Vida FLaSH Acquisitions (Medtech SPAC)

Scott Huennekens will deliver the Keynote address at the 2021 Emerging Medtech Summit.  He will also sit on a panel to discuss the current state of Medtech SPACs.

Huennekens is a successful executive, entrepreneur, board member and investor in medical devices having been the start-up CEO of multiple “unicorns” and a part of 10+ startups or growth companies with market valuations that have totaled over $6B and more importantly > 20 million patients that have benefited from the therapies & diagnostics of these companies. He currenty serves as Chairman of the Board for Acutus Medical and Vida FLaSH Acquisitions Corp (Medtech SPAC).   Scott served as Pres & CEO of Verb Surgical, Google and J&J’s new Surgical Robotics start-up to revolutionize the future of surgery in January. Previously, Scott led Volcano Corp., as its first and only Pres. & CEO, from start-up in 2002 to its IPO in 2006 and sale to Philips in 2015.  Prior to this, he was at Digirad Corporation, a diagnostic imaging solutions provider, from 1997 to 2002, as President & CEO. Digirad went public in 2004 (DRAD). Scott graduated Magna Cum Laude with a BS in Business Administration from the Univ. of Southern California in 1986 and earned his MBA from the Harvard Business School in 1991. Current professional affiliations include Board Member Nuvasive (NUVA), Board Member ViewRay (VRAY), Board Member TDi, Board of Advisors Peloton Ventures, Board Member and past Chairman MDMA.

Paul LaViolette, Managing Partner SV Health, Medtech Convergence Fund

Paul LaViolette will join us at the 2021 Emerging Medtech Summit during a Fireside Chat to kick off the event.  He'll also attend the event to network and connect with other investors, innovators and strategics.

LaViolette has over 35 years of global medical technology management experience.  He is an active investor, industry insider and sits on the Board of several medical device companies.  He also currently serves as Managing Partner & COO of SV and heads up their medical device investments.

Prior to SV, Paul built and ran medical device businesses for 29 years before joining SV Health Investors. Most recently he was Chief Operating Officer at Boston Scientific (BSC), an $8 billion medical device leader. During his 15 years at BSC, Paul served as Chief Operating Officer; Group President, Cardiovascular; President, Cardiology; Group President, Endosurgery; and President, International. During his tenure, the company grew revenue over 20 times. Paul integrated two dozen acquisitions and led extensive product development, manufacturing and worldwide commercial organizations. Previously, Paul held marketing and general management positions at CR Bard and various marketing roles at Kendall (Medtronic).

Outside of SV, Paul serves as Chairman of the Medical Device Manufacturing Association and as Vice Chairman of the Innovation Advisory Board for the Partners Health System. Paul also served on the board of Advamed for 10 years and is a routine speaker at industry meetings.

Nicholas Pachuda, Former J&J and Current SVP at Peptilogics

Dr. Nicholas Pachuda will be the moderator for the LSI 2021 Strategic Panel. Nick's panelists will include strategics and corporate investors with decades of experience working with entrepreneurs from seed to late stage. They'll share insights, success stories (plus a few war stories), and provide a strategic partnering roadmap for medical technology innovators and their investors.

Renee Ryan, CEO, Cala Health

Renee Ryan is recognized as an industry insider and leading investor, deal-maker, and innovator.  She will present Cala Health at the 2021 Emerging Medtech Summit.

Ryan has 25 years of building category-creating healthcare companies. She led the medical technology investments for Johnson & Johnson Innovation (JJDC) on the West Coast and Asia Pacific for 8 years. While at J&J, she made over 15 new investments, including the Series A for Cala Health. Previously, she was a healthcare investment banker at RW Baird, Jefferies and Goldman Sachs

Brian Shields, CEO, Neurent Medical

Brian Shields presented Neurent Medical at LSI's 2020 Emerging Medtech Summit and has since then continued to lead his company through significant fundraising and other key milestones.  

Shields is the co-founder and CEO of Neurent Medical. Brian spent almost a decade working as a management consultant much of this time spent on the design and commercial rollout of connected health clinical programmes in public and private European health systems and “around the pill” services for the pharmaceutical industry. Brian and David founded Neurent Medical, raising their first capital in 2017. Brian has a PhD in Applied Computing and an MBA.

Ken Nelson, CEO, Investor, Advisor

Ken Nelson will attend the 2021 Emerging Medtech Summit to network and connect with other investors, strategics and innovators.  Ken presented at LSI's 2020 event as the Chief Commercialization Officer of Bardy Diagnostics.

Nelson currently serves as Head of Digital Health, Diagnostics, & Monitoring at Biotronik.  He has deep industry experience and a 20 year track record in digital health, medical device, and remote patient monitoring.  Nelson is an executive and innovator with successful senior leadership experience ranging from a Fortune 500 company (Boston Scientific) to 3 start-ups, 1 of which eventually led to an extremely successful IPO (iRhythm) and another which is well on its way to doing the same (Bardy Diagnostics).

Jennifer Fried, CEO & Co-Founder of ExplORer Surgical

Jennifer is the CEO and Co-Founder of ExplORer Surgical. Jennifer founded the company with Dr. Alex Langerman as an MBA student at the University of Chicago Booth School of Business, where she received her degree with honors in Finance and Entrepreneurship. Learn more:​

Bruce Lichorowic, CEO of Galen Robotics

Bruce Lichorowic is President & CEO of Galen Robotics. He will be a panelist on the Innovation Panel “Opportunities in the Drive Towards Intelligent Surgery” at the LSI 2021 Emerging Medtech Summit.

Lloyd Diamon, CEO of Pixium

Enjoy this opportunity to hear what Lloyd Diamond, CEO of Pixium, has to say about his innovation and the upcoming LSI 2021 Emerging Medtech Summit. Pixium is a retinal implant system designed to help treat degenerative eye conditions such as retinitis pigmentosa and macular degeneration. Learn more about Pixium at​

Kwame Ulmer Venture Partner, Wavemaker Three-Sixty Health

Kwame Ulmer will be moderating the Investor Panel “Medtech VC & Corporate Investing Trends” at the LSI 2021 Emerging Medtech Summit.

Kwame Ulmer is a MedTech executive with nearly 20 years of government and private sector experience. He integrates his time working as an operating company executive, evaluating over 1,000 technologies at the FDA, advising early stage companies, and formal business education to help clients set a clear regulatory strategy and deliver on key milestones. Kwame is based in Southern California.

David Uffer, Partner, Alira Health

David Uffer is a widely recognized and connected medtech insider.  He will attend the 2021 Emerging Medtech Summit to represent Alira Health's extensive advisory services and to network with other industry insiders and company CEOs. Uffer will moderate a panel on the topic of strategic deal-making and corporate partnering.

Uffer has over 25 years of management experience in clinical diagnostics, product development, and the medical device industry. His focus on strategy, planning, and business development allows him to provide comprehensive solutions to clients. David has worked with global mid- and large-cap companies across the U.S., Europe, and Asia.

Susan Wood President & CEO at VIDA

Dr. Wood has 20+ years of experience championing innovative clinical solutions to the marketplace, from concept to revenue. She most recently held the position of Executive Vice President of Marketing and Technology for Vital Images, an innovative advanced visualization software company. Prior to Vital Images, Dr. Wood served as VP of marketing at R2 Technology (now Hologic), where she championed the development, regulatory approval and commercial release of the first FDA approved (PMA) software product for the automatic detection of lung nodules in both diagnostic and screening chest CT examinations. Learn More:​

Joe Muldoon, CEO, Fast Biomedical

Joe Muldoon will be a presenting company representing Fast Biomedical at the 2021 Emerging Medtech Summit.

Muldoon leverages 30 years of experience, from technology startups to publicly traded multinationals.  He has been involved in several companies serving as an investor, CEO, and advisor in many cases.  Joe has advised companies such as TGX Medical, Vasc-Alert, Trust Bearer Labs, and Geist Pharmaceuticals.  Joe has a Bachelor of Science in Business from Indiana University’s Kelley School of Business.

Robert Ball and David Blue, CEO/CCO of Shoulder Innovations

Robert Ball and David Blue, CEO and CCO of Shoulder Innovations respectively, share how LSI helped forge a connection that led to the largest fundraising Shoulder Innovations has seen to date (and much more). Shoulder Innovations continues to revolutionize shoulder arthroplasty and, more importantly, improve procedure longevity, ultimately changing patients lives. Learn more at:

Manny Villafana, Chairman & CEO at Medical 21

Dr. Manny Villafaña is the Founder, Chairman, & CEO of Medical 21, Inc. Dr. Villafaña is globally recognized as a “Living Legend of Medicine.” He is an award-winning USA Master Entrepreneur and a member of the Halls of Fame of Minnesota Business and Science & Technology. He is the past founder of medical device companies that have transformed the industry of cardiac surgery and improved the lives of millions. Manny is also the recipient of an honorary Doctorate of Sciences degree from the University of Iowa. Learn More: